Literature DB >> 23466249

Physician-patient communication about dietary supplements.

Derjung M Tarn1, Debora A Paterniti, Jeffrey S Good, Ian D Coulter, James M Galliher, Richard L Kravitz, Arun S Karlamangla, Neil S Wenger.   

Abstract

OBJECTIVE: Describe the content and frequency of provider-patient dietary supplement discussions during primary care office visits.
METHODS: Inductive content analysis of 1477 transcribed audio-recorded office visits to 102 primary care providers was combined with patient and provider surveys. Encounters were collected in Los Angeles, CA (2009-2010), geographically diverse practice settings across the United States (2004-2005), and Sacramento, CA (1998-1999).
RESULTS: Providers discussed 738 dietary supplements during encounters with 357 patients (24.2% of all encounters in the data). They mentioned: (1) reason for taking the supplement for 46.5% of dietary supplements; (2) how to take the supplement for 28.2%; (3) potential risks for 17.3%; (4) supplement effectiveness for 16.7%; and (5) supplement cost or affordability for 4.2%. Of these five topics, a mean of 1.13 (SD=1.2) topics were discussed for each supplement. More topics were reviewed for non-vitamin non-mineral supplements (mean 1.47 (SD=1.2)) than for vitamin/mineral supplements (mean 0.99 (SD=1.1); p<0.001).
CONCLUSION: While discussions about supplements are occurring, it is clear that more discussion might be needed to inform patient decisions about supplement use. PRACTICE IMPLICATIONS: Physicians could more frequently address topics that may influence patient dietary supplement use, such as the risks, effectiveness, and costs of supplements.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23466249      PMCID: PMC3648214          DOI: 10.1016/j.pec.2013.01.021

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  28 in total

Review 1.  Safety issues with herbal products.

Authors:  C M Marrone
Journal:  Ann Pharmacother       Date:  1999-12       Impact factor: 3.154

Review 2.  Emerging role of integrative medicine in cardiovascular disease.

Authors:  Mehmet Oz
Journal:  Cardiol Rev       Date:  2004 Mar-Apr       Impact factor: 2.644

Review 3.  Herbal remedies.

Authors:  Peter A G M De Smet
Journal:  N Engl J Med       Date:  2002-12-19       Impact factor: 91.245

4.  Ethnicity and physician-older patient communication about alternative therapies.

Authors:  B Sleath; R H Rubin; W Campbell; L Gwyther; T Clark
Journal:  J Altern Complement Med       Date:  2001-08       Impact factor: 2.579

5.  Request fulfillment in office practice: antecedents and relationship to outcomes.

Authors:  Richard L Kravitz; Robert A Bell; Rahman Azari; Edward Krupat; Steven Kelly-Reif; David Thom
Journal:  Med Care       Date:  2002-01       Impact factor: 2.983

6.  Adverse drug events as a cause of hospital admission in the elderly.

Authors:  M Chan; F Nicklason; J H Vial
Journal:  Intern Med J       Date:  2001 May-Jun       Impact factor: 2.048

7.  Physicians want education about complementary and alternative medicine to enhance communication with their patients.

Authors:  Lisa Corbin Winslow; Howard Shapiro
Journal:  Arch Intern Med       Date:  2002-05-27

8.  How oncologists discuss complementary therapy use with their patients: an audio-tape audit.

Authors:  Penelope E Schofield; Ilona Juraskova; Phyllis N Butow
Journal:  Support Care Cancer       Date:  2003-04-24       Impact factor: 3.603

Review 9.  Adverse effects of herbal treatment of cardiovascular disease: what the physician must know.

Authors:  J F Villegas; D N Barabe; R A Stein; E Lazar
Journal:  Heart Dis       Date:  2001 May-Jun

10.  Intervention to enhance communication about newly prescribed medications.

Authors:  Derjung M Tarn; Debora A Paterniti; Deborah K Orosz; Chi-Hong Tseng; Neil S Wenger
Journal:  Ann Fam Med       Date:  2013 Jan-Feb       Impact factor: 5.166

View more
  13 in total

1.  Analysis of oral dietary supplement use in rural older adults.

Authors:  Marcia Y Shade; Matthew Witry; Katie Robinson; Kevin Kupzyk
Journal:  J Clin Nurs       Date:  2019-01-17       Impact factor: 3.036

2.  Natural Product Dietary Supplement Use by Individuals With Rheumatoid Arthritis: A Scoping Review.

Authors:  Janel C DeSalvo; Meghan B Skiba; Carol L Howe; Karen E Haiber; Janet L Funk
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-05-03       Impact factor: 4.794

3.  Practical Application of "About Herbs" Website: Herbs and Dietary Supplement Use in Oncology Settings.

Authors:  Yen-Nien Hou; Gary Deng; Jun J Mao
Journal:  Cancer J       Date:  2019 Sep/Oct       Impact factor: 3.360

4.  Longitudinal use of complementary and alternative medicine among older adults with radiographic knee osteoarthritis.

Authors:  Shibing Yang; Catherine E Dubé; Charles B Eaton; Timothy E McAlindon; Kate L Lapane
Journal:  Clin Ther       Date:  2013-10-18       Impact factor: 3.393

5.  Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.

Authors:  Derjung M Tarn; Maureen Barrientos; Angel Y Wang; Abhijit Ramaprasad; Margaret C Fang; Janice B Schwartz
Journal:  J Am Geriatr Soc       Date:  2019-10-28       Impact factor: 5.562

6.  Identifying and assessing views among physically-active adult gym members in Israel on dietary supplements.

Authors:  Inbal Druker; Anat Gesser-Edelsburg
Journal:  J Int Soc Sports Nutr       Date:  2017-09-21       Impact factor: 5.150

7.  The Prevalence of Dietary Supplement Use among College Students: A Nationwide Survey in Japan.

Authors:  Etsuko Kobayashi; Yoko Sato; Keizo Umegaki; Tsuyoshi Chiba
Journal:  Nutrients       Date:  2017-11-15       Impact factor: 5.717

8.  Behaviors of consumers, physicians and pharmacists in response to adverse events associated with dietary supplement use.

Authors:  Tsuyoshi Chiba; Yoko Sato; Etsuko Kobayashi; Kazuki Ide; Hiroshi Yamada; Keizo Umegaki
Journal:  Nutr J       Date:  2017-03-18       Impact factor: 3.271

9.  Oroxylum indicum extract, at a physiologically relevant dosage, does not induce hepatotoxicity in C57BL/6J mice.

Authors:  Satyanarayana R Pondugula; Julia M Salamat; Kodye L Abbott; Patrick C Flannery; Mohammed Majrashi; Mohammed Almaghrabi; Manoj Govindarajulu; Sindhu Ramesh; Suneel K Onteru; Maninder Sandey; Chen-Che Huang; Kristina Gill; Natasha Narayanan; Edwin McElroy; Darshini Desai; Rishi Nadar; Timothy Moore; Kalyanam Nagabhushanam; Muhammed Majeed; Muralikrishnan Dhanasekaran
Journal:  Nat Prod Commun       Date:  2021-05-18       Impact factor: 1.496

10.  Patient-physician discussions about costs: definitions and impact on cost conversation incidence estimates.

Authors:  Wynn G Hunter; Ashley Hesson; J Kelly Davis; Christine Kirby; Lillie D Williamson; Jamison A Barnett; Peter A Ubel
Journal:  BMC Health Serv Res       Date:  2016-03-31       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.